Ingevity Corp Files 8-K: Director Changes & Officer Compensation Updates

Ticker: NGVT · Form: 8-K · Filed: 2025-07-01T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, executive-compensation, director-change

Related Tickers: NGVT

TL;DR

Ingevity's 8-K: Director out, new director in, exec pay changes. Governance update.

AI Summary

On July 1, 2025, Ingevity Corporation filed an 8-K report detailing the departure of a director, the election of a new director, and updates to compensatory arrangements for certain officers. The filing also includes information regarding Regulation FD disclosures and financial statements and exhibits.

Why It Matters

This filing signals potential shifts in corporate governance and executive compensation strategies at Ingevity Corporation.

Risk Assessment

Risk Level: low — The filing primarily concerns routine corporate governance and executive compensation matters, with no immediate financial distress or significant operational changes indicated.

Key Players & Entities

Ingevity Corporation (company) — Registrant
July 1, 2025 (date) — Date of Report

FAQ

Who is the departing director and when did their departure become effective?

The filing indicates the departure of a director, but the specific name and effective date are not detailed in the provided text.

Who is the newly elected director and what is their background?

The filing mentions the election of a new director, but their name and background are not specified in the provided text.

What specific changes are being made to the compensatory arrangements for certain officers?

The filing notes updates to compensatory arrangements for certain officers, but the specific details of these changes are not included in the provided text.

Are there any Regulation FD disclosures included in this filing?

Yes, the filing explicitly states that it includes Regulation FD disclosures.

What other items are included as exhibits with this 8-K filing?

The filing indicates that financial statements and exhibits are included, but the specific list of exhibits is not provided in the text.

From the Filing

0001641172-25-017264.txt : 20250701 0001641172-25-017264.hdr.sgml : 20250701 20250701064615 ACCESSION NUMBER: 0001641172-25-017264 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250701 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250701 DATE AS OF CHANGE: 20250701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ingevity Corp CENTRAL INDEX KEY: 0001653477 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 474027764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37586 FILM NUMBER: 251094133 BUSINESS ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 BUSINESS PHONE: 8437402300 MAIL ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 8-K 1 form8-k.htm 8-K false 0001653477 0001653477 2025-07-01 2025-07-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       FORM 8-K       CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 July 1, 2025   Date of Report (date of earliest event reported)       INGEVITY CORPORATION (Exact name of registrant as specified in its charter)       Delaware   001-37586   47-4027764 (State or other jurisdiction of incorporation or organization)   (Commission File Number)   (I.R.S. Employer Identification No.)   4920 O’Hear Avenue Suite 400   29405 North Charleston South Carolina   (Zip code) (Address of principal executive offices)       Registrant’s telephone number, including area code: 843 - 740-2300   Not Applicable (Former name or former address, if changed since last report)       Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock ($0.01 par value)   NGVT   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   ☐ Emerging growth company   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐             ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers   On July 1, 2025 (the “Separation Date”), S. Edward Woodcock, Executive Vice President and President, Performance Ma